Sunesis Pharmaceuticals, Inc.'s Flop: More Drugs Out There, Says Roth By: Benzinga via Benzinga October 07, 2014 at 16:19 PM EDT Sunesis Pharmaceuticals, Inc.'s (NASDAQ: SNSS) failed cancer drug vosaroxin offers no reason for investors to give up hope on ... Read More >> Related Stocks: Pharmaroth Labs Inc